- Open Access
The instructive role of dendritic cells on T-cell responses
© BioMed Central Ltd 2002
- Received: 27 February 2002
- Accepted: 4 March 2002
- Published: 9 May 2002
Immune responses are initiated in the T-cell areas of secondary lymphoid organs where naïve T lymphocytes encounter dendritic cells (DCs) that present antigens taken up in peripheral tissues. DCs represent the interface between the universe of foreign and tissue-specific antigens and T lymphocytes, and they are the key players in the regulation of cell-mediated immunity. We discuss how the nature of the DC maturation stimuli and the density and quality of DCs present in the T-cell areas of secondary lymphoid organs determine the magnitude and class of the T-cell response.
- dendritic cells
- effector and memory T cells
- T-cell activation
- T-cell tolerance
DCs possess specialized features, such as pathogen recognition, antigen capturing and processing machinery, migratory capacity and costimulatory molecules, that allow them to act as the professional antigen presenting cells (APC) . DCs represent the interface between the universe of foreign and tissue-specific antigens and T lymphocytes. They also play a role in all aspects of T-cell responses, from the deletion of self-reactive thymocytes to the generation of effector and memory cells, as well as the induction of peripheral tolerance.
In this review, we shall discuss how DCs provide a qualitative and quantitative framework for T-cell antigen recognition. We shall first summarize the requirements for T-cell activation and differentiation in terms of concentration of peptide–MHC complexes, costimulatory molecules and cytokines. We shall then consider how DCs assemble these components and deliver them, as discrete short-lived packets, to the T-cell areas. Finally, we shall discuss how the nature of the DC maturation stimuli determines the density and quality of antigen-carrying DCs and, consequently, the magnitude and class of T-cell responses.
DC maturation is triggered and modulated by a variety of receptors for microbial products, cytokines and T cells [12, 13]. Human monocyte derived and myeloid DCs express several Toll-like receptors such as TLR2 and TLR4 that trigger maturation in response to bacterial peptidoglycan and lipopolysaccharide, respectively. Interestingly, these receptors are absent in plasmacytoid DCs (also known as interferon-producing cells [IPC]) that instead express TLR9, which mediates the response to CpG DNA [14, 15]. The differential responsiveness of myeloid and plasmacytoid DCs to pathogens underlines a division of labour between human DC subsets. DC maturation can be also triggered by tumour necrosis factor (TNF)-α and IL-1, and can be inhibited by IL-10. Finally, all DC types are exquisitely sensitive to T-cell feedback signals delivered by activated T cells through CD40 ligand (CD40L).
The maturation process coordinately regulates antigen capturing, processing and presentation, expression of costimulatory molecules, cytokine production and lifespan. Immature DCs are extremely efficient in antigen capture since they possess high levels of constitutive macropinocytosis and express endocytic receptors for microbial patterns, such as the mannose receptor . Maturation increases synthesis of MHC class II molecules, while decreasing their degradation, thus favouring the rapid accumulation of long-lived peptide–MHC complexes, which are retained for several days, while class II synthesis is shut off . Presentation on MHC class I molecules is also enhanced by an approximately 10-fold increase in the rate of synthesis, which is sustained in mature DCs . DCs are capable of transporting phagocytosed antigens from the endocytic compartment to the cytosol, leading to their 'cross-presentation' to CD8+ T cells [19, 20]. Finally, maturation stimuli upregulate the expression of B7.1 and B7.2, thus enhancing the T-cell stimulatory capacity of DCs. While the upregulation of MHC molecules ensures higher capacity for antigen presentation, upregulation of costimulatory molecules ensures an efficient amplification of signalling in naïve T cells.
Because the half-life of mature DCs is short and because cytokine production is transient, the number and type of DCs present in the T-cell areas will reflect, in highly dynamic fashion, the conditions of the tissues from which the lymph is drained. Under steady-state conditions, only a few tissue-resident DCs 'spontaneously' mature and migrate to the draining lymph nodes, carrying antigens and apoptotic bodies taken up in peripheral tissues . These migrating DCs do not induce effector responses, but rather trigger an abortive T-cell proliferation that leads to immunological tolerance [24, 25]. It is possible that spontaneously matured DCs deliver to T cells a qualitatively distinct tolerizing signal. Alternatively, according to the progressive differentiation model, we suggest that the low frequency and short lifespan of these DCs, together with the low level of antigen and B7, may deliver a weak stimulus to T cells, which is not sufficient to sustain proliferation and to promote differentiation.
When pathogens (or adjuvants) are present in peripheral tissues, resident DCs are activated en masse and migrate to the draining lymph nodes. At the same time monocytes are recruited from peripheral blood into inflamed tissues, where they rapidly differentiate to DCs that capture antigens and, on maturation, migrate to the draining lymph nodes. This mechanism sustains antigen sampling and presentation for extended periods of time. Maturing DCs produce large amounts of inflammatory cytokines and chemokines that promote monocyte recruitment . The relative role of tissue-resident DCs, such as Langerhans cells and dermal DCs, versus recruited DCs, such as monocyte-derived DCs and IPC, remains to be established. Production of IFN-I by IPC may be important to promote maturation of monocytes and to protect them from the cytopathic effects of viruses [27, 28].
In summary, under inflammatory conditions, the T-cell areas of draining lymph nodes receive large numbers of highly stimulatory DCs for a sustained period of time. The high DC density and the high levels of antigen and B7 molecules deliver a strong and sustained stimulation to specific T cells, leading to their rapid proliferation and differentiation. High levels of IL-2 are produced under these conditions and drive clonal expansion of committed T cells irrespective of whether they continue to receive TCR stimulation. One should also consider that DC–T cell interaction results in a reciprocal stimulation. Activated T cells trigger DCs via CD40L or TNF-related activation-induced cytokine, improving their T-cell stimulatory capacity, boosting IL-12 production, and prolonging their lifespan . It is possible that regulatory T cells may suppress antigen presentation by DCs via production of inhibitory cytokines or by direct contact .
There is growing evidence that the capacity of DCs to induce Th1 or Th2 responses is contingent on appropriate stimulation and timing (Fig. 3). As already discussed, myeloid DCs produce IL-12 only in response to some pathogens or CD40L, and within a narrow time window. In addition, IPC produce large amounts of IFN-I, another Th1-polarizing cytokine, in response to viruses but not in response to CD40L; again, only within a narrow time window. In contrast, Th2 responses may be induced by DCs that do not produce Th1-polarizing cytokines, either because they have been conditioned by nonpermissive stimuli or because they have exhausted their IL-12 or IFN-I-producing capacity. In this case, Th2 polarization is driven by IL-4 produced by T cells themselves or derived from exogenous sources, such as natural killer T cells or mast cells. It is worth considering that the dynamics of DC migration to the draining lymph nodes may lead to preferential generation of Th1 cells during the early phases of the immune response, when active DCs enter the T-cell areas in large numbers. This is followed by induction of Th2 and nonpolarized T cells at later time points when the influx of DCs ceases and the DCs surviving in the T-cell area exhaust their IL-12-producing capacity .
The availability of antigen-presenting DCs and of antigen-specific T-cell precursors represents the limiting factors in the immune responses. There is growing evidence that responding T cells compete in vivo for access to DCs and that this competition can be relieved by providing more DCs . At the initial phase of a primary response, the low frequency of naïve T cells specific for a given antigen makes competition among responding cells unlikely. However, as the responding cells proliferate, competition for sustained TCR stimulation will increase, particularly among cells of the same clone, which have the same avidity and occupy the same niche. This intraclonal competition contributes to functional diversification: T cells achieving a sustained stimulation differentiate to effector cells, while those receiving a short stimulation remain in an intermediate state giving rise to central memory T cells. In contrast, interclonal competition may take place preferentially in secondary responses due to the larger numbers of antigen-specific cells present, and may therefore explain the selection of high-avidity T cells under these circumstances.
It is becoming increasingly clear that DCs provide the adaptive immune system with the essential function of context discrimination. DCs can integrate multiple stimuli from pathogens, inflammatory cytokines and T cells, and can provide distinct outputs in terms of antigen presentation, costimulation and cytokine production. Like other cells involved in the innate immune response, DCs produce large amounts of inflammatory chemokines that contribute to the recruitment of DC precursors in inflamed tissues, thus sustaining antigen sampling in peripheral tissue and presentation to T cells in lymph nodes. Finally, the T-cell activation and differentiation programme translates antigen concentration, cytokine and costimulatory molecule composition, and DC density into distinct cell fates ranging from tolerance to inflammation, cytotoxicity and memory.
APC = antigen presenting cells; CD40L = CD40 ligand; DC = dendritic cell; IPC = interferon-producing cells.
A Lanzavecchia is supported by the Helmut Horten Foundation and by the Swiss National Science Foundation (grant no. 31-63885). This work was supported in part by the European Community (contract no. QLK2-CT-201-0105).
- Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature. 1998, 392: 245-252. 10.1038/32588.PubMedView ArticleGoogle Scholar
- Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A: Three-dimensional segregation of supramolecular activation clusters in T cells. Nature. 1998, 395: 82-86. 10.1038/25764.PubMedView ArticleGoogle Scholar
- Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML: The immunological synapse: a molecular machine controlling T cell activation. Science. 1999, 285: 221-227. 10.1016/S0009-2614(98)00031-1.PubMedView ArticleGoogle Scholar
- Lanzavecchia A, Iezzi G, Viola A: From TCR engagement to T cell activation: a kinetic view of T cell behavior. Cell. 1999, 96: 1-4.PubMedView ArticleGoogle Scholar
- Lanzavecchia A, Sallusto F: Antigen decoding by T lymphocytes: from synapses to fate determination. Nat Immunol. 2001, 2: 487-492. 10.1038/88678.PubMedView ArticleGoogle Scholar
- Viola A, Schroeder S, Sakakibara Y, Lanzavecchia A: T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science. 1999, 283: 680-682. 10.1126/science.283.5402.680.PubMedView ArticleGoogle Scholar
- Iezzi G, Karjalainen K, Lanzavecchia A: The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity. 1998, 8: 89-95.PubMedView ArticleGoogle Scholar
- Iezzi G, Scheidegger D, Lanzavecchia A: Migration and function of antigen-primed nonpolarized T lymphocytes in vivo. J Exp Med. 2001, 193: 987-993. 10.1084/jem.193.8.987.PubMedPubMed CentralView ArticleGoogle Scholar
- Langenkamp A, Messi M, Lanzavecchia A, Sallusto F: Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol. 2000, 1: 311-316. 10.1038/79758.PubMedView ArticleGoogle Scholar
- Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999, 401: 708-712. 10.1038/44385.PubMedView ArticleGoogle Scholar
- Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994, 179: 1109-1118.PubMedView ArticleGoogle Scholar
- Reis e Sousa C, Sher A, Kaye P: The role of dendritic cells in the induction and regulation of immunity to microbial infection. Curr Opin Immunol. 1999, 11: 392-399. 10.1016/S0952-7915(99)80066-1.PubMedView ArticleGoogle Scholar
- Lanzavecchia A, Sallusto F: The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr Opin Immunol. 2001, 13: 291-298. 10.1016/S0952-7915(00)00218-1.PubMedView ArticleGoogle Scholar
- Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, Liu YJ: Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med. 2001, 194: 863-869. 10.1084/jem.194.6.863.PubMedPubMed CentralView ArticleGoogle Scholar
- Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavecchia A: Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol. 2001, 31: 3388-3393. 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q.PubMedView ArticleGoogle Scholar
- Sallusto F, Cella M, Danieli C, Lanzavecchia A: Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med. 1995, 182: 389-400.PubMedView ArticleGoogle Scholar
- Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A: Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature. 1997, 388: 782-787. 10.1038/42030.PubMedView ArticleGoogle Scholar
- Cella M, Salio M, Sakakibara Y, Langen H, Julkunen I, Lanzavecchia A: Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med. 1999, 189: 821-829. 10.1084/jem.189.5.821.PubMedPubMed CentralView ArticleGoogle Scholar
- Albert ML, Sauter B, Bhardway N: Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 1998, 392: 86-89. 10.1038/32183.PubMedView ArticleGoogle Scholar
- Rodriguez A, Regnault A, Kleijmeer M, Ricciardi-Castagnoli P, Amigorena S: Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat Cell Biol. 1999, 1: 362-368. 10.1038/14058.PubMedView ArticleGoogle Scholar
- Kalinsky P, Hilkens C, Wierenga E, Kapsenberg M: T cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today. 1999, 20: 561-567. 10.1016/S0167-5699(99)01547-9.View ArticleGoogle Scholar
- Cella M, Scheidegger D, Palmer Lehmann K, Lane P, Lanzavecchia A, Alber G: Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T–T help via APC activation. J Exp Med. 1996, 184: 747-752.PubMedView ArticleGoogle Scholar
- Huang FP, Platt N, Wykes M, Major JR, Powell TJ, Jenkins CD, MacPherson GG: A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med. 2000, 191: 435-444. 10.1084/jem.191.3.435.PubMedPubMed CentralView ArticleGoogle Scholar
- Kurts C, Kosaka H, Carbone FR, Miller JF, Heath WR: Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med. 1997, 186: 239-245. 10.1084/jem.186.2.239.PubMedPubMed CentralView ArticleGoogle Scholar
- Hernandez J, Aung S, Redmond WL, Sherman LA: Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J Exp Med. 2001, 194: 707-717. 10.1084/jem.194.6.707.PubMedPubMed CentralView ArticleGoogle Scholar
- Sallutso F, Palermo B, Lenig D, Meittinen M, Matikainen S, Julkunen I, Forster R, Burgstahler R, Lipp M, Lanzevecchia A: Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol. 1999, 29: 1617-1625. 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3.View ArticleGoogle Scholar
- Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S, Liu YJ: The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999, 284: 1835-1837. 10.1126/science.284.5421.1835.PubMedView ArticleGoogle Scholar
- Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, Colonna M: Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 1999, 5: 919-923. 10.1038/11360.PubMedView ArticleGoogle Scholar
- Wong BR, Josien R, Lee SY, Sauter B, Li H, Steinman RM, Choi Y: TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med. 1997, 186: 2075-2080. 10.1084/jem.186.12.2075.PubMedPubMed CentralView ArticleGoogle Scholar
- Vendetti S, Chai JG, Dyson J, Simpson E, Lombardi G, Lechler R: Anergic T cells inhibit the antigen-presenting function of dendritic cells. J Immunol. 2000, 165: 1175-1181.PubMedView ArticleGoogle Scholar
- Lanzavecchia A, Sallusto F: Dynamics of T lymphocyte responses: intermediates, effectors and memory cells. Science. 2000, 290: 92-97. 10.1016/S0378-4371(00)00362-9.PubMedView ArticleGoogle Scholar
- Kedl RM, Rees WA, Hildeman DA, Schaefer B, Mitchell T, Kappler J, Marrack P: T cells compete for access to antigen-bearing antigen-presenting cells. J Exp Med. 2000, 192: 1105-1113. 10.1084/jem.192.8.1105.PubMedPubMed CentralView ArticleGoogle Scholar